Bio-Techne signals mid-single-digit underlying growth for fiscal 2026, with margin expansion and cell therapy normalization ahead
SmartKem, Inc. Common Stock · Now $0.30
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS